Oral Wegovy Pill: The First GLP-1 Weight Loss Pill (2026 Guide)

The FDA approved the first GLP-1 pill for weight loss in late 2025 — here's what it costs, how well it works, and how it compares to injections and compounded options.

The breakthrough

What Is the Oral Wegovy Pill? #

In late 2025, the FDA approved oral semaglutide (marketed as Wegovy in tablet form) as the first GLP-1 receptor agonist pill for chronic weight management. Novo Nordisk launched it in US pharmacies in January 2026, and it became the most dynamic pharmaceutical story of the year — hitting 2 million total prescriptions by mid-April 2026, just 14 weeks after launch.

The pill contains the same active ingredient as injectable Wegovy — semaglutide — but uses a novel absorption enhancer called SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) that protects the drug from stomach acid and helps it cross the stomach lining. This is the same technology used in Rybelsus (oral semaglutide for diabetes), but at a higher dose optimized for weight loss.

Key facts:

• Active ingredient: Semaglutide (same as Wegovy injection and Ozempic)
• Dose: Once daily, titrating up to 25mg
• FDA indication: Chronic weight management in adults with BMI 30+ or BMI 27+ with at least one weight-related condition
• Cardiovascular benefit: Also approved for reducing major adverse cardiovascular events

Clinical evidence

How Well Does the Wegovy Pill Work? #

The OASIS clinical trial program studied oral semaglutide 25mg in thousands of patients:

OASIS 4 results (the approval trial):

• 16.6% mean body weight loss at 64 weeks with full treatment adherence
• 2.7% in the placebo group — confirming the weight loss is from the drug, not lifestyle changes alone
• Comparable to injectable Wegovy, which achieves 15-17% average weight loss in the STEP trials

Side effects are also similar to injectable semaglutide:

• Nausea (40-50%, most common in first 4 weeks at each dose increase)
• Constipation (25-30%)
• Diarrhea (15-20%)
• Most side effects improve after your body adjusts to each dose

What it costs

Cost Comparison: Oral Wegovy vs Other Options #

How to use it

How to Take the Wegovy Pill #

The oral Wegovy pill has specific requirements for absorption:

1. Take on an empty stomach — at least 30 minutes before the first food, drink, or other medications of the day
2. Swallow whole with up to 4 ounces (120ml) of plain water only — not juice, coffee, or other liquids
3. Do not crush, chew, or split the tablet
4. Wait at least 30 minutes before eating, drinking anything other than water, or taking other oral medications
5. Take once daily at approximately the same time each day

Dose titration schedule:

• Weeks 1-4: 3mg daily
• Weeks 5-8: 7mg daily
• Weeks 9-12: 14mg daily
• Week 13+: 25mg daily (maintenance dose)

The gradual dose increase helps minimize nausea and GI side effects.

Decision guide

Who Should Consider the Oral Wegovy Pill? #

The pill may be right for you if:

• You have a needle phobia or strongly prefer not to inject
• Your insurance covers oral Wegovy (check your formulary)
• You can commit to the empty-stomach morning routine
• You want FDA-approved brand-name medication

You might prefer injectable or compounded semaglutide if:

• You don’t want to deal with daily dosing (injectable is once weekly)
• You can’t get insurance coverage and want the lowest price ($129/mo compounded)
• You travel frequently and the empty-stomach timing is difficult
• You’re already on injectable semaglutide and doing well

You might prefer compounded semaglutide if:

• Price is your primary concern — compounded starts at $129/mo vs $149/mo for oral Wegovy
• You don’t have insurance coverage for brand-name Wegovy
• You want same-day telehealth approval without prior authorization

Getting started

How to Get GLP-1 Medications Affordably #

Telehealth Platforms That Prescribe GLP-1s #

FAQ

Frequently Asked Questions #

What is the oral Wegovy pill?

Oral Wegovy is the first FDA-approved GLP-1 pill for weight loss. It contains the same active ingredient as injectable Wegovy — semaglutide — but in a once-daily tablet form. The FDA approved it in late 2025 and it became available in US pharmacies in January 2026. The maximum dose is 25mg taken once daily.

How much weight can you lose on the Wegovy pill?

In the OASIS 4 clinical trial, oral semaglutide 25mg achieved 16.6% mean body weight loss at 64 weeks with full adherence. This is comparable to but slightly lower than injectable Wegovy’s 15-17% average weight loss. The oral form is slightly less effective at higher doses because of lower bioavailability compared to injection.

How much does the Wegovy pill cost?

Novo Nordisk set the list price for oral Wegovy at approximately $149 per month without insurance. With insurance coverage, the copay can be as low as $25. This is significantly cheaper than injectable Wegovy at retail ($1,300+/mo) but still more expensive than compounded semaglutide via telehealth, which starts at $129/month.

Is the oral Wegovy pill better than the injection?

It depends on your priorities. The pill is more convenient (no needles) and cheaper at list price ($149 vs $1,300+/mo). However, injectable semaglutide has slightly higher bioavailability, meaning more of the drug reaches your system. Clinical results are comparable — 16.6% weight loss for oral vs 15-17% for injectable. The pill must be taken on an empty stomach with minimal water and requires a 30-minute fast afterward.

Can I switch from injectable Wegovy to the pill?

Yes, but discuss the transition with your provider. The dosing schedules are different — injectable Wegovy is weekly while the pill is daily. Your provider will determine the appropriate starting dose for the oral form based on your current injectable dose. Some patients find the daily routine easier to remember; others prefer the once-weekly injection.

How does the Wegovy pill compare to compounded semaglutide?

Oral Wegovy is FDA-approved and manufactured by Novo Nordisk — it’s brand-name semaglutide in pill form at $149/mo. Compounded semaglutide is a custom-made injectable version from licensed pharmacies starting at $129/mo via telehealth. The compounded version is injectable (not a pill) but costs less and doesn’t require insurance. Both contain the same active ingredient.

Keep reading

Related Guides #

Sources

Key References #

1. Knop FK, Aroda VR, et al. Oral semaglutide 50 mg taken once daily in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. 2023;402(10403):705-719. DOI
2. Novo Nordisk. FDA approves Novo Nordisk’s Wegovy pill, the first and only oral GLP-1 for weight loss in adults. Press Release. 2025.
3. Aroda VR, et al. Oral semaglutide in adults with overweight or obesity: OASIS 4 trial results. NEJM. 2024.

Affiliate Disclosure: Some links earn a small commission at no extra cost to you. I only recommend platforms I've researched thoroughly.